Angiodynamics (ANGO) Non Operating Income (2015 - 2026)
Angiodynamics (ANGO) posted Non Operating Income of -$4.8 million for Q2 2026, down 197.68% on a QoQ basis from $4.9 million in Q1 2026, and up 9.49% year-over-year from -$4.4 million in Q2 2025.
Angiodynamics (ANGO) Non Operating Income (2015 - 2026) Analysis & Trends
Angiodynamics' Non Operating Income history runs 12 years deep, the most recent figure standing at -$4.8 million for Q2 2026.
- Quarterly Non Operating Income rose 9.49% year-over-year to -$4.8 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$121000.0 (down 112.37% YoY) and the FY2026 annual result came in at -$299000.0, down 130.57% from the prior year.
- Non Operating Income was -$4.8 million for Q2 2026 at Angiodynamics, down from $4.9 million in the prior quarter.
- Across five years, Non Operating Income topped out at $5.6 million in Q1 2025 and bottomed at -$5.3 million in Q2 2025.
- A 5-year average of -$54722.2 and a median of -$199500.0 in 2023 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 3467.31% in 2025, while the deepest fall reached 568.09% in 2025.
- Angiodynamics' Non Operating Income stood at -$936000.0 in 2022, then jumped by 157.05% to $534000.0 in 2023, then sank by 53.93% to $246000.0 in 2024, then plunged by 193.5% to -$230000.0 in 2025, then sank by 1972.17% to -$4.8 million in 2026.
- Business Quant data shows ANGO's Non Operating Income at -$4.8 million in Q2 2026, $4.9 million in Q1 2026, and -$230000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 82.70 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -131.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 12.29 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 3.50 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -62.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.93 Mn |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | -4.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -4.77 Mn |
| Feb 28, 2026 | 4.88 Mn |
| Nov 30, 2025 | -230,000.00 |
| Aug 31, 2025 | -4,000.00 |
| May 31, 2025 | -5.27 Mn |
| Feb 28, 2025 | 5.57 Mn |
| Nov 30, 2024 | 246,000.00 |
| Aug 31, 2024 | 433,000.00 |
| May 31, 2024 | 1.13 Mn |
| Feb 29, 2024 | 156,000.00 |
| Nov 30, 2023 | 534,000.00 |
| Aug 31, 2023 | -169,000.00 |
| May 31, 2023 | -474,000.00 |
| Feb 28, 2023 | -736,000.00 |
| Nov 30, 2022 | -936,000.00 |
| Aug 31, 2022 | -556,000.00 |
| May 31, 2022 | -324,000.00 |
| Feb 28, 2022 | -462,000.00 |
| Nov 30, 2021 | -184,000.00 |
| Aug 31, 2021 | -508,000.00 |